» Articles » PMID: 38814097

Characterization of Recombinant Human Lactoferrin Expressed in

Overview
Journal Analyst
Specialty Chemistry
Date 2024 May 30
PMID 38814097
Authors
Affiliations
Soon will be listed here.
Abstract

This work presents a thorough characterization of Helaina recombinant human lactoferrin (rhLF, Effera™) expressed in a yeast system at an industrial scale for the first time. Proteomic analysis confirmed that its amino acid sequence is identical to that of native human LF. N-linked glycans were detected at three known glycosylation sites, namely, Asparagines-156, -497, and -642 and they were predominantly oligomannose structures having five to nine mannoses. Helaina rhLF's protein secondary structure was nearly identical to that of human milk lactoferrin (hmLF), as revealed by microfluidic modulation spectroscopy. Results of small-angle X-ray scattering (SAXS) and analytical ultracentrifugation analyses confirmed that, like hmLF, Helaina rhLF displayed well-folded globular structures in solution. Reconstructed solvent envelopes of Helaina rhLF, obtained through the SAXS analysis, demonstrated a remarkable fit with the reported crystalline structure of iron-bound native hmLF. Differential scanning calorimetry investigations into the thermal stability of Helaina rhLF revealed two distinct denaturation temperatures at 68.7 ± 0.9 °C and 91.9 ± 0.5 °C, consistently mirroring denaturation temperatures observed for apo- and holo-hmLF. Overall, Helaina rhLF differed from hmLF in the N-glycans they possessed; nevertheless, the characterization results affirmed that Helaina rhLF was of high purity and exhibited globular structures closely akin to that of hmLF.

Citing Articles

A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults.

Peterson R, Guarneiri L, Adams C, Wilcox M, Clark A, Rudemiller N Int J Toxicol. 2024; 44(1):12-28.

PMID: 39465888 PMC: 11731406. DOI: 10.1177/10915818241293723.


Evaluation of the potential food allergy risks of human lactoferrin expressed in .

Anaya Y, Rosario Martinez R, Goodman R, Johnson P, Vajpeyi S, Lu X Front Immunol. 2024; 15:1380028.

PMID: 39114650 PMC: 11303282. DOI: 10.3389/fimmu.2024.1380028.


Digestive Profiles of Human Milk, Recombinant Human and Bovine Lactoferrin: Comparing the Retained Intact Protein and Peptide Release.

Kim B, Kuhfeld R, Haas J, Anaya Y, Rosario Martinez R, Sah B Nutrients. 2024; 16(14).

PMID: 39064803 PMC: 11280017. DOI: 10.3390/nu16142360.

References
1.
Ward P, Piddington C, Cunningham G, Zhou X, Wyatt R, Conneely O . A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic. Biotechnology (N Y). 1995; 13(5):498-503. DOI: 10.1038/nbt0595-498. View

2.
Yang Y, Thannhauser T, Li L, Zhang S . Development of an integrated approach for evaluation of 2-D gel image analysis: impact of multiple proteins in single spots on comparative proteomics in conventional 2-D gel/MALDI workflow. Electrophoresis. 2007; 28(12):2080-94. DOI: 10.1002/elps.200600524. View

3.
Dong A, Huang P, Caughey W . Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry. 1990; 29(13):3303-8. DOI: 10.1021/bi00465a022. View

4.
Thomas C, Cleland T, Zhang S, Gundberg C, Vashishth D . Identification and characterization of glycation adducts on osteocalcin. Anal Biochem. 2017; 525:46-53. PMC: 5490980. DOI: 10.1016/j.ab.2017.02.011. View

5.
Zlatina K, Galuska S . The -glycans of lactoferrin: more than just a sweet decoration. Biochem Cell Biol. 2020; 99(1):117-127. DOI: 10.1139/bcb-2020-0106. View